Dyadic International Inc (DYAI)
1.12
-0.02
(-1.75%)
USD |
NASDAQ |
Nov 13, 16:00
1.13
+0.01
(+0.89%)
After-Hours: 20:00
Dyadic International Debt to Equity Ratio: 1.721 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.721 |
| March 31, 2024 | 1.290 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | -16.00 |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | -3.592 |
| September 30, 2014 | |
| March 31, 2014 | 7.036 |
| December 31, 2013 | 3.210 |
| September 30, 2013 | 2.764 |
| June 30, 2013 | 1.871 |
| March 31, 2013 | 10.83 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
1.721
Maximum
Jun 2024
0.1585
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| AIM ImmunoTech Inc | 0.4322 |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 0.7145 |
| Electromed Inc | 0.00 |
| Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 10.63M |
| Total Liabilities (Quarterly) | 7.462M |
| Shareholders Equity (Quarterly) | 3.168M |
| Current Ratio | 5.390 |
| Net Debt Paydown Yield | -2.50% |